SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-247622
Filing Date
2020-09-17
Accepted
2020-09-17 08:00:32
Documents
12
Period of Report
2020-09-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d38465d8k.htm   iXBRL 8-K 23036
  Complete submission text file 0001193125-20-247622.txt   145000

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cue-20200917.xsd EX-101.SCH 3078
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cue-20200917_lab.xml EX-101.LAB 18122
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cue-20200917_pre.xml EX-101.PRE 11411
5 EXTRACTED XBRL INSTANCE DOCUMENT d38465d8k_htm.xml XML 3337
Mailing Address 21 ERIE STREET CAMBRIDGE MA 02139
Business Address 21 ERIE STREET CAMBRIDGE MA 02139 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 201180129
SIC: 2834 Pharmaceutical Preparations